JCR Pharmaceuticals Co., Ltd. (4552.T)
JPY 610.0
(-0.81%)
JPY 610.0
(-0.81%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 20.93 Billion JPY | 13.07% |
| 2022 | 18.51 Billion JPY | 26.5% |
| 2021 | 14.63 Billion JPY | 7.98% |
| 2020 | 13.55 Billion JPY | 53.07% |
| 2019 | 8.85 Billion JPY | -2.87% |
| 2018 | 9.11 Billion JPY | 1.04% |
| 2017 | 9.02 Billion JPY | 16.61% |
| 2016 | 7.73 Billion JPY | 5.38% |
| 2015 | 7.34 Billion JPY | 14.7% |
| 2014 | 6.4 Billion JPY | 25.39% |
| 2013 | 5.1 Billion JPY | 2.31% |
| 2012 | 4.99 Billion JPY | -2.35% |
| 2011 | 5.11 Billion JPY | 11.71% |
| 2010 | 4.57 Billion JPY | 11.65% |
| 2009 | 4.09 Billion JPY | 27.46% |
| 2008 | 3.21 Billion JPY | -3.74% |
| 2007 | 3.33 Billion JPY | -8.94% |
| 2006 | 3.66 Billion JPY | -7.24% |
| 2005 | 3.95 Billion JPY | -14.17% |
| 2004 | 4.6 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 22.27 Billion JPY | -1.27% |
| 2024 Q2 | 22.76 Billion JPY | 5.44% |
| 2023 Q1 | 18.27 Billion JPY | -1.27% |
| 2023 Q3 | 20.83 Billion JPY | 8.08% |
| 2023 Q2 | 19.27 Billion JPY | 5.44% |
| 2023 Q4 | 20.93 Billion JPY | 0.49% |
| 2023 FY | 20.93 Billion JPY | 13.07% |
| 2022 Q2 | 15.81 Billion JPY | 10.52% |
| 2022 Q4 | 18.51 Billion JPY | 8.4% |
| 2022 FY | 18.51 Billion JPY | 26.5% |
| 2022 Q1 | 14.3 Billion JPY | -2.25% |
| 2022 Q3 | 17.07 Billion JPY | 8.01% |
| 2021 Q3 | 15.74 Billion JPY | 4.64% |
| 2021 Q4 | 14.63 Billion JPY | -7.04% |
| 2021 FY | 14.63 Billion JPY | 7.98% |
| 2021 Q1 | 15.19 Billion JPY | 12.09% |
| 2021 Q2 | 15.04 Billion JPY | -0.97% |
| 2020 Q1 | 9.84 Billion JPY | 11.19% |
| 2020 Q4 | 13.55 Billion JPY | 23.94% |
| 2020 FY | 13.55 Billion JPY | 53.07% |
| 2020 Q2 | 10.41 Billion JPY | 5.8% |
| 2020 Q3 | 10.93 Billion JPY | 4.98% |
| 2019 Q1 | 9.4 Billion JPY | 3.16% |
| 2019 FY | 8.85 Billion JPY | -2.87% |
| 2019 Q3 | 9.47 Billion JPY | -5.01% |
| 2019 Q4 | 8.85 Billion JPY | -6.54% |
| 2019 Q2 | 9.97 Billion JPY | 6.06% |
| 2018 Q1 | 8.83 Billion JPY | -2.08% |
| 2018 FY | 9.11 Billion JPY | 1.04% |
| 2018 Q4 | 9.11 Billion JPY | -5.16% |
| 2018 Q3 | 9.61 Billion JPY | 8.58% |
| 2018 Q2 | 8.85 Billion JPY | 0.2% |
| 2017 Q1 | 8.47 Billion JPY | 9.53% |
| 2017 FY | 9.02 Billion JPY | 16.61% |
| 2017 Q2 | 9.13 Billion JPY | 7.82% |
| 2017 Q4 | 9.02 Billion JPY | -7.23% |
| 2017 Q3 | 9.72 Billion JPY | 6.43% |
| 2016 Q4 | 7.73 Billion JPY | -10.63% |
| 2016 FY | 7.73 Billion JPY | 5.38% |
| 2016 Q3 | 8.65 Billion JPY | 1.31% |
| 2016 Q2 | 8.54 Billion JPY | 7.15% |
| 2016 Q1 | 7.97 Billion JPY | 8.61% |
| 2015 Q3 | 7.72 Billion JPY | 9.0% |
| 2015 Q2 | 7.08 Billion JPY | 7.95% |
| 2015 Q1 | 6.56 Billion JPY | 2.58% |
| 2015 Q4 | 7.34 Billion JPY | -4.98% |
| 2015 FY | 7.34 Billion JPY | 14.7% |
| 2014 FY | 6.4 Billion JPY | 25.39% |
| 2014 Q4 | 6.4 Billion JPY | -2.17% |
| 2014 Q3 | 6.54 Billion JPY | 4.49% |
| 2014 Q2 | 6.26 Billion JPY | 21.54% |
| 2014 Q1 | 5.15 Billion JPY | 0.92% |
| 2013 FY | 5.1 Billion JPY | 2.31% |
| 2013 Q1 | 4.99 Billion JPY | 0.06% |
| 2013 Q2 | 4.69 Billion JPY | -5.91% |
| 2013 Q3 | 5.47 Billion JPY | 16.51% |
| 2013 Q4 | 5.1 Billion JPY | -6.73% |
| 2012 Q2 | 5.34 Billion JPY | -0.22% |
| 2012 Q4 | 4.99 Billion JPY | -1.45% |
| 2012 FY | 4.99 Billion JPY | -2.35% |
| 2012 Q1 | 5.36 Billion JPY | 4.89% |
| 2012 Q3 | 5.06 Billion JPY | -5.33% |
| 2011 FY | 5.11 Billion JPY | 11.71% |
| 2011 Q4 | 5.11 Billion JPY | -6.61% |
| 2011 Q3 | 5.47 Billion JPY | 3.18% |
| 2011 Q2 | 5.3 Billion JPY | 12.78% |
| 2011 Q1 | 4.7 Billion JPY | 2.78% |
| 2010 Q3 | 4.74 Billion JPY | 2.99% |
| 2010 Q4 | 4.57 Billion JPY | -3.58% |
| 2010 FY | 4.57 Billion JPY | 11.65% |
| 2010 Q1 | 4.24 Billion JPY | 3.5% |
| 2010 Q2 | 4.6 Billion JPY | 8.63% |
| 2009 FY | 4.09 Billion JPY | 27.46% |
| 2009 Q2 | 3.81 Billion JPY | 0.0% |
| 2009 Q4 | 4.09 Billion JPY | 4.3% |
| 2009 Q3 | 3.92 Billion JPY | 2.84% |
| 2008 Q3 | 3.01 Billion JPY | 0.0% |
| 2008 Q4 | 3.21 Billion JPY | 6.7% |
| 2008 FY | 3.21 Billion JPY | -3.74% |
| 2007 FY | 3.33 Billion JPY | -8.94% |
| 2006 FY | 3.66 Billion JPY | -7.24% |
| 2005 FY | 3.95 Billion JPY | -14.17% |
| 2004 FY | 4.6 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Kyowa Kirin Co., Ltd. | 71.36 Billion JPY | 70.667% |
| Astellas Pharma Inc. | 248.73 Billion JPY | 91.584% |
| Chugai Pharmaceutical Co., Ltd. | 273.48 Billion JPY | 92.346% |
| Ono Pharmaceutical Co., Ltd. | 48.62 Billion JPY | 56.954% |
| Santen Pharmaceutical Co., Ltd. | 43.18 Billion JPY | 51.527% |
| Daiichi Sankyo Company, Limited | 438.11 Billion JPY | 95.222% |
| Otsuka Holdings Co., Ltd. | 249.58 Billion JPY | 91.613% |
| Perseus Proteomics Inc. | 4.4 Million JPY | -475002.133% |